Solid Biosciences's total assets for Q1 2025 were $343.90M, an increase of 82.29% from the previous quarter. SLDB total liabilities were $49.44M for the fiscal quarter, a -3.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.